OTCMKTS:TRUMY Terumo (TRUMY) Stock Price, News & Analysis $15.78 -0.38 (-2.35%) As of 03:32 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsNews and TrendsShort Interest About Terumo Stock (OTCMKTS:TRUMY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Terumo alerts:Sign Up Key Stats Today's Range$15.29▼$15.8150-Day Range$13.25▼$16.4352-Week Range$12.08▼$16.81Volume65,512 shsAverage Volume235,403 shsMarket Capitalization$23.28 billionP/E Ratio22.23Dividend Yield0.38%Price TargetN/AConsensus RatingStrong Buy Company Overview Terumo Corporation is a Japan-based medical technology company that develops and manufactures products for hospitals, clinics and other healthcare providers. Founded in 1921, the company began by producing clinical thermometers and has since expanded into a broad range of medical devices and services. Terumo’s businesses include cardiovascular and vascular products, such as catheter-based devices and systems used in the treatment of heart and vascular conditions; medical care products, including infusion and injection devices; and blood and cell technologies used to collect, process and manage blood and cellular therapies. Headquartered in Tokyo, Terumo serves healthcare customers in Japan and markets around the world. Its products support areas including patient care, cardiovascular treatment, transfusion medicine and cell therapy.AI Generated. May Contain Errors. Read More Receive TRUMY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Terumo and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TRUMY Stock News HeadlinesTerumo ADR (TRUMY) RatiosOctober 24, 2026 | uk.investing.comTerumo ADR (TRUMY)September 5, 2026 | es.investing.comWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.November 10 at 1:00 AM | Porter & Company (Ad)Terumo Corporation (TRUMY) Q1 2027 Earnings Call Prepared Remarks TranscriptAugust 12, 2026 | seekingalpha.comTerumo Corporation (TRUMY) Analyst/Investor Day TranscriptJune 12, 2026 | seekingalpha.comTerumo ADR Stock Price HistoryMay 17, 2026 | investing.comTerumo Corporation (TRUMY) Q4 2026 Earnings Call TranscriptMay 17, 2026 | seekingalpha.comTerumo Corporation (TRUMY) Q3 2026 Earnings Call TranscriptFebruary 13, 2026 | seekingalpha.comSee More Headlines TRUMY Stock Analysis - Frequently Asked Questions How have TRUMY shares performed this year? Terumo's stock was trading at $14.49 at the beginning of 2026. Since then, TRUMY shares have increased by 8.5% and is now trading at $15.7278. How were Terumo's earnings last quarter? Terumo Corp. (OTCMKTS:TRUMY) announced its quarterly earnings results on Friday, August, 7th. The company reported $0.30 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.13. The firm had revenue of $1.97 billion for the quarter, compared to the consensus estimate of $1.84 billion. Terumo had a net margin of 13.83% and a trailing twelve-month return on equity of 10.44%. When did Terumo's stock split? Shares of Terumo split on Thursday, March 28th 2024.The 2-1 split was announced on Thursday, March 28th 2024. The newly created shares were issued to shareholders after the market closes on Thursday, March 28th 2024. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. How do I buy shares of Terumo? Shares of TRUMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/07/2026Today11/10/2026Next Earnings (Estimated)11/12/2026Fiscal Year End3/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:TRUMY Previous SymbolNASDAQ:TRUMY CIK1446672 Webwww.terumo.com Phone(133) 374-8111Fax813-3374-8399Employees30,000Year Founded1964Profitability EPS (Trailing Twelve Months)$0.71 Trailing P/E Ratio22.21 Forward P/E Ratio19.71 P/E GrowthN/ANet Income$897.03 million Net Margins13.83% Pretax Margin15.75% Return on Equity10.44% Return on Assets7.34% Debt Debt-to-Equity Ratio0.13 Current Ratio2.19 Quick Ratio1.37 Sales & Book Value Annual Sales$7.52 billion Price / Sales3.09 Cash Flow$1.09 per share Price / Cash Flow14.50 Book Value$7.09 per share Price / Book2.22Miscellaneous Outstanding Shares1,475,070,000Free FloatN/AMarket Cap$23.26 billion OptionableNot Optionable Beta0.82 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (OTCMKTS:TRUMY) was last updated on 11/10/2026 by MarketBeat.com Staff. From Our PartnersBlack Friday Bombshell (for traders)For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredThe Withdrawal You'll Never See on Your StatementA proposal circulating in Washington, dubbed the Mar-a-Lago Accord, calls for tariffs and currency pressure to...Bishop Gold Group | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredIt’s now or neverAnthropic's Claude now generates more revenue than ChatGPT, and the company is about to go public at a $1.5 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terumo Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Terumo With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
